Lawsuits have been filed alleging that Sanofi-Aventis, the manufacturer of Zantac, failed to warn consumers that the drug could cause dangerous levels of a potential carcinogen if ingested.
Lawyers working are now investigating whether additional lawsuits can be filed on behalf of Zantac users diagnosed with cancer. Those cases, if successful, could help pay for medical costs and other losses associated with using Zantac. You can also pop over to this website so as to get to know that you are eligible for filing a lawsuit or not.
Image Source: Google
Why was the lawsuit filed?
The lawsuits first come after an online pharmacy told the FDA that they had "extremely high levels" of a possible carcinogen called n-nitrosodimethylamine (NDMA) in Zantac. The "innate instability" of ranitidine can cause it to react with itself to produce NDMA. Tests conducted by pharmacies found more than 3 million nanograms of NDMA per tablet, which is more than 31,000 times the FDA's maximum daily dose.
The lawsuit claims that Zantac's maker, Sanofi, knew Zantac could be converted to NDMA in the body, but still did not warn consumers about the serious health risks – including cancer associated with using the drug.
Is this action a class action?
Although lawsuits have been filed for allegedly misrepresenting Zantac as "safe and effective" by Sanofi, those lawsuits are usually aimed at reimbursing consumers for the money they spent on the drug itself rather than for damages related to damage to cancer progression.
What can we get from the lawsuit?
If successful, Zantac users may be able to get money back for:
- Medical bills
- Lost wages
- Mental torture
- Physical pain